COVID-19 Oral Therapeutic (with Sen-Jam Pharmaceutical)
COVID-19
DevelopmentActive
Key Facts
About KVK Tech
KVK Tech is a private, commercial-stage generic pharmaceutical company headquartered in Newtown, Pennsylvania, USA. It has established itself as a manufacturer of high-quality, FDA-approved generic medicines, with a notable branded product, Lomaira (phentermine), and a strong commitment to U.S.-based manufacturing and quality. The company's strategy focuses on cost-effective alternatives for patients, though it navigates a competitive generic landscape and has faced recent legal scrutiny, as indicated by a deferred prosecution agreement in its public filings.
View full company profileTherapeutic Areas
Other COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| COVID-19 Severity Prediction Test | Age Labs | Development |
| PanCytoVir™ (oral probenecid) | TrippBio | Phase 2 |
| ARCoV | Abogen | Approved (EUA) |
| OT-101 | Sapu BioScience | Clinical Trial (Phase not specified) |
| COVID-19 Vaccine (Inactivated) | Kangtai Biological Products | Approved |
| COVID-19 Vaccine (Adenovirus Vector) | Kangtai Biological Products | Approved |
| Idylla SARS-CoV-2 Test | Biocartis | Approved |
| Adjuvanted Cell-Based COVID-19 Vaccine | CSL Seqirus | Marketed |
| Sequential Dialysis Technique | Halberd | Discovery |
| Amubarvimab + Romlusevimab (BRII-196/BRII-198) | Brii Biosciences | Approved |
| COVID-19 Vaccine Testing (for AstraZeneca) | Advaxia Biologics | Approved |
| COVID-19 Vaccine Clinical Batches | Advaxia Biologics | Clinical |